US 7687521
Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7687521 (Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity) held by Theravance, Inc. expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P29/00